---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-046992"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2021-09-02T23:59:59+00:00"
generated_at: "2026-06-29T06:10:52.915754+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Crinetics appoints Jeff Knight as COO with $400k salary, 40% bonus, and 160k-share option grant

## Summary
- Appointment effective August 30, 2021; Knight most recently SVP at Poseida Therapeutics.
- Annual base salary of $400,000 with target annual incentive bonus of 40% of base.
- Received option to purchase 160,000 shares vesting 25% on Aug 30, 2022 then monthly over 3 years.
- Sign-on bonus of $40,000 in connection with commencement of employment.
- Knight brings over 25 years of clinical drug development experience.

## SEC filing metadata
- accession: 0001564590-21-046992
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2021-09-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/0001564590-21-046992-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/crnx-8k_20210830.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-046992
- JSON: https://secwatch.observer/filing/0001564590-21-046992.json
- Plain text: https://secwatch.observer/filing/0001564590-21-046992.txt

## Key facts
- Executive change
  Jeff Knight was appointed as Chief Operating Officer at Crinetics Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On September 2, 2021, Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) announced the appointment of Jeff Knight as the Company’s Chief Operating Officer, which was effective as of August 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/0001564590-21-046992-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.